Am J Physiol Cell Physiol Watch the video to see how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Cell Physiol 290: C650-C659, 2006. First published September 21, 2005; doi:10.1152/ajpcell.00163.2005
0363-6143/06 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/2/C650    most recent
00163.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (10)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sultan, K. R.
Right arrow Articles by Haagsman, H. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sultan, K. R.
Right arrow Articles by Haagsman, H. P.

METHODS IN CELL PHYSIOLOGY

Quantification of hormone-induced atrophy of large myotubes from C2C12 and L6 cells: atrophy-inducible and atrophy-resistant C2C12 myotubes

Karim R. Sultan,1,3 Birgit Henkel,3 Maarten Terlou,2 and Henk P. Haagsman1

1Faculty of Veterinary Medicine and 2Department of Biology, Academic Biomedical Centre, Utrecht University, Utrecht, The Netherlands; and 3Institute of Biochemistry and Molecular Biology II: Molecular Cell Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Submitted 7 April 2005 ; accepted in final form 12 September 2005

Myofiber atrophy is the final outcome of muscle wasting induced by catabolic factors such as glucocorticoids and thyroid hormones. We set up an in vitro system to define the catabolic reaction based on myotube atrophy. Both mouse C2C12 and rat L6 cells were used. C2C12 myotube formation was improved by replacing horse serum with the serum substitute Ultroser G. A new method was developed to quantify size changes of large (0.5–1 mm) myotubes only, excluding remaining myoblasts and small myotubes. Dexamethasone reduced myotube size by 30% in L6 but not in C2C12 myotubes. Expression of the glucocorticoid receptor was twofold higher in L6 myotubes than in C2C12 myotubes. In both cell lines, 3,3',5-triiodo-L-thyronine (T3) did not induce a significant size reduction. Expression of the major T3 receptor (T3R{beta}1) was higher in L6 myotubes. We investigated whether the changes in myotube size are related to changes in atrogin-1 expression, as this enzyme is thought to be a key factor in the initiation of muscle atrophy. Dexamethasone induced a twofold increase of atrogin-1 mRNA; again, only L6 myotubes were susceptible. Interestingly, atrogin-1 expression in Ultroser G-fused C2C12 myotubes was lower than that in horse serum-fused myotubes. Furthermore, dexamethasone treatment increased atrogin-1 expression only in horse serum-fused myotubes but not in Ultroser G-fused myotubes. Ultroser G-induced fusion may result in atrophy-resistant C2C12 myotubes. Therefore, C2C12 myotubes offer an ideal system in which to study skeletal muscle atrophy because, depending on differentiation conditions, C2C12 cells produce atrophy-inducible and atrophy-resistant myotubes.

glucocorticoids; nuclear receptors; atrogin



Address for reprint requests and other correspondence: H. P. Haagsman, Div. of Public Health and Food Safety, Faculty of Veterinary Medicine, Utrecht Univ., PO Box 80.175, NL-3508 TD Utrecht, The Netherlands (e-mail: H.P.Haagsman{at}vet.uu.nl)




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
J. Naderi, C. Bernreuther, N. Grabinski, C. T. Putman, B. Henkel, G. Bell, M. Glatzel, and K. R. Sultan
Plasminogen Activator Inhibitor Type 1 Up-Regulation Is Associated with Skeletal Muscle Atrophy and Associated Fibrosis
Am. J. Pathol., August 1, 2009; 175(2): 763 - 771.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
M. Nishimura, M. Mikura, K. Hirasaka, Y. Okumura, T. Nikawa, Y. Kawano, M. Nakayama, and M. Ikeda
Effects of Dimethyl Sulphoxide and Dexamethasone on mRNA Expression of Myogenesis- and Muscle Proteolytic System-related Genes in Mouse Myoblastic C2C12 Cells
J. Biochem., December 1, 2008; 144(6): 717 - 724.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. Yin, Z. Gao, D. Liu, Z. Liu, and J. Ye
Berberine improves glucose metabolism through induction of glycolysis
Am J Physiol Endocrinol Metab, January 1, 2008; 294(1): E148 - E156.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
K. Nakanishi, N. Dohmae, and N. Morishima
Endoplasmic reticulum stress increases myofiber formation in vitro
FASEB J, September 1, 2007; 21(11): 2994 - 3003.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.